Weaver Consulting Group’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-2,310
Closed -$115K 486
2020
Q3
$115K Hold
2,310
0.07% 173
2020
Q2
$102K Sell
2,310
-156
-6% -$6.67K 0.06% 186
2020
Q1
$93K Buy
2,466
+138
+6% +$5.81K 0.06% 168
2019
Q4
$96K Buy
2,328
+576
+33% +$24.2K 0.05% 172
2019
Q3
$73K Hold
1,752
0.04% 192
2019
Q2
$70K Sell
1,752
-846
-33% -$32K 0.04% 185
2019
Q1
$102K Buy
+2,598
New +$94.3K 0.03% 321

Other funds holding IHI

Weaver Consulting Group's IHI Position: Q4 2020 in Review

Weaver Consulting Group sold out of iShares US Medical Devices ETF (IHI) in Q4 2020, closing a stake of 2,310 shares — an estimated $115K sold.

Weaver Consulting Group first reported a position in IHI in Q1 2019 and held it in 7 quarters. The position peaked at $115K in Q3 2020. 582 funds tracked by Wall St. Rank hold IHI as of Q4 2020.

  • Weaver Consulting Group reported no remaining iShares US Medical Devices ETF position as of Q4 2020 after selling out during the quarter.
  • Weaver Consulting Group sold 2,310 iShares US Medical Devices ETF shares in Q4 2020, an estimated $115K.
  • Weaver Consulting Group first reported a position in iShares US Medical Devices ETF in Q1 2019 and held it in 7 quarters.
  • Weaver Consulting Group's iShares US Medical Devices ETF position peaked at $115K in Q3 2020.
  • 582 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q4 2020.

Based on Weaver Consulting Group's 13F filing for Q4 2020, filed 29 Jan 2021.